1st Quarter - Report

FAEGRE DRINKER BIDDLE & REATH LLP for DRUGS FOR NEGLECTED DISEASES INITIATIVE OF NORTH AMERICA

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY 2019 State and Foreign Operation Appropriation Bill; Provisions related to neglected tropical disease research and development; FY 2019 funding for neglected tropical disease research and development; FY 2019 Funding for antimicrobial resistance and research and development; FY 2019 Labor, Health and Human Services & Education appropriations bill; H.R. 1625, Consolidated Appropriations Act of 2018.

LobbyistCovered position, as disclosed
JODIE CURTIS —
JERRICA MATHIS —

Contacted: SENATE

Bills named: H.R. 1625 (115th)

Medical/Disease Research/Clinical Labs MED

Neglected Tropical Disease Research and Development; HR 1415 End Neglected Disease Act; Draft NTD legislation.

LobbyistCovered position, as disclosed
JODIE CURTIS —
JERRICA MATHIS —

Contacted: SENATE

Bills named: H.R. 1415 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.